ExploreWatchlistsPricing
  1. JP-listed companies
  2. Renascience Inc.
  3. Financials
  4. Earnings per share

Renascience Inc. (4889)

Market cap
¥20B
P/E ratio
-39.5x
Rena Science develops pharmaceuticals, medical devices, and AI-powered software to address critical health challenges including cancer, diabetes, and age-related diseases.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 2026-23.4-362.22%
Mar 31, 20258.9-143.90%
Mar 31, 2024-20.3-23.09%
Mar 31, 2023-26.4+18.32%
Mar 31, 2022-22.3+119.14%
Mar 31, 2021-10.2-45.65%
Mar 31, 2020-18.7-99.60%
Mar 31, 2019-4,682.6-99.21%
Mar 31, 2018-594,040.4+3292.84%
Mar 31, 2017-17,508.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat